Eli Lilly and Company Share Price & Technical Analysis

LLY · $1,072 (+0.70%)

Healthcare / Drug Manufacturers - General

AI Score 70 · Neutral

$1,072

+0.70%

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70

Price chart

Seasonality

May has 4 positive and 1 negative years (last 5 years shown)

12% return in May, 0% avg return in past 3 year May month.

-1% return in 2026, 42% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-4%1%-12%1%12%-1%
254%14%-10%10%-13%6%-5%-2%5%13%24%0%48%
2411%16%1%1%6%10%-12%15%-8%-7%-4%-3%27%
23-6%-9%11%15%8%9%-3%22%-3%3%6%-1%52%
22-11%1%16%2%8%3%2%-8%7%11%7%-2%37%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 70/100

Neutral · Strong · Strong

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$883.32B

P/E ratio

35.2

52W high

$1,134

52W low

$623.8

Volume

18,80,467

Beta

0.48

Related stocks in Healthcare

Frequently asked questions

What is Eli Lilly and Company share price today?
Eli Lilly and Company (LLY) last traded around $1,072 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does LLY have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LLY. Download the app for real-time alerts.
How can I analyze Eli Lilly and Company stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro